Concepedia

Publication | Open Access

Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome

DOIFull Paper Access

37

Citations

21

References

2020

Year

María Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, Daniele Curreli, Germana Cecchini, Caterina Bodio, C. Grossi, Simonetta Blengino, Anǵela Tincani, Franco Franceschini,

Unknown Venue

Abstract

aPL show a low prevalence in COVID-19 patients and are not associated with major thrombotic events. aPL in COVID-19 patients are mainly directed against β2GPI but display an epitope specificity different from antibodies in antiphospholipid syndrome.

References

YearCitations

Page 1